Home
About Us
About MediRama
Mission & Vision
Why MediRama
Leadership team
MD Professional
Core Service
What does
MediRama do?
Resources
Publication & News
Events & Webinars
Careers
Careers
Contact us
KOR
KOR
ENG
Resources
Resources
[MediRama EDGE] When Companion Diagnostics Change: Assays, Cutoffs, Samples and Regulatory Inputs in Oncology Drug Development.
작성자:
관리자
등록일:
2026-03-03
When Companion Diagnostics Change: Assays, Cutoffs, Samples and Regulatory Inputs in Oncology Drug Development.
송출일 : 2026.02.26
https://www.youtube.com/watch?v=5ZMexgAGs4A
PREV
[MediRama EDGE] A Review of Clinical Pharmacology Considerations in Antibody–Drug Conjugates Approved by the US Food and Drug Administration Between 2000 and 2025.
다음글이 존재하지 않습니다.
NEXT
목록으로
공유
라인
밴드
네이버
페이스북
X
복사